Materialise NV Reports Resilient Q2 2025 Performance

Materialise NV ( (MTLS) ) has released its Q2 earnings. Here is a breakdown of the information Materialise NV presented to its investors.

Materialise NV, headquartered in Belgium, is a prominent player in the additive manufacturing sector, offering advanced 3D printing services and medical software solutions across various industries including healthcare and automotive.

In its second quarter of 2025 earnings report, Materialise NV reported a decline in total consolidated revenue by 5.8% compared to the same period in 2024, while its Materialise Medical segment showed significant growth of 16.7%. Despite the revenue drop, the company maintained a positive net result, highlighting its operational resilience amidst challenging economic conditions.

Key financial metrics revealed that the company’s gross profit margin improved to 58.3%, up from 57.0% in the previous year. Adjusted EBIT for the quarter was 3,058 kEUR, showing improvement from the first quarter of 2025 but still below the previous year’s figure. The Materialise Medical segment was a standout performer with a 32.7% adjusted EBITDA margin, while the Manufacturing segment faced challenges with a negative EBITDA margin.

The company’s net cash position increased by 2,025 kEUR, driven by positive free cash flow in the first half of 2025. However, unfavorable exchange rate fluctuations significantly impacted the financial results, contributing to a net profit of 199 kEUR for the quarter, down from 3,875 kEUR in the same period of 2024.

Looking ahead, Materialise NV remains cautious due to geopolitical and macroeconomic uncertainties, adjusting its revenue guidance for the full fiscal year to a range of 265,000 to 280,000 kEUR. Despite these challenges, the company is confident in its solid business fundamentals and aims to maintain operational profitability through continued cost efficiencies.